ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch in European Union countries and the United Kingdom of...
Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagn...
SAN JOSE, Calif. & TEMPE, Ariz. & PETACH TIKVA, Israel--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the addition of restorative capabilities t...
Participating US doctors will have access to patient financing solutions for nearly every patient Participating US doctors will have access to patient financing solutions for nearly every patient
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $225 million of Align's common stock thr...
US stocks had a great 2024 but there still were names last year that failed to capitalise on the positive sentiment. A handful of them, however, are fairly positioned for a comeback this year, according to analysts at Jefferies.
ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System has been approve...
Align Technology (ALGN 0.75%), known for its Invisalign clear aligners and digital dental systems, announced its fourth-quarter 2024 results on Feb. 5, 2025. The earnings release highlighted stable performance amid currency and demand challenges.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.